Despite recent developments in intensive care, sepsis remains one of the leading problems faced by clinicians involved in the field. Sepsis is the cause of approximately 34.0% and 37.4% admissions to Polish and European intensive care units (ICU), respectively, and it is associated with very high mortality, reaching 32.2% among patients with severe sepsis [1, 2]. Alarmingly, there is an upward trend in its prevalence and mortality rate worldwide [3]. Furthermore, sepsis is a crucial issue for the policymakers, due to the high cost of ICU treatment, estimated to be $27,461 per case, and the significant re-hospitalisation rate among sepsis survivors, reaching 63% [4, 5]. Considering the aforementioned data, precise and reliable predictive factors in sepsis are needed. However, the search for further prognostic biomarkers is ongoing. Sepsis is associated with dysfunction of multiple organs. Respiratory failure, hypotension, and/ or shock contribute to hypoxia, thus reducing the